Critical appraisal of in situ cell kinetic measurements as response predictors in human tumors

Seminars in Radiation Oncology

Volumn 3, Issue 2, 1993, Pages 144-151

  Begg, Adrian C ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CELL DNA; THYMIDINE;

CANCER RADIOTHERAPY; CELL KINETICS; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; DNA SYNTHESIS; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; LABELING INDEX; OROPHARYNX CANCER; PREDICTION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; TUMOR GROWTH; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0027416972     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-4296(05)80090-6     Document Type: Article

References (39)

1. The hazard of accelerated tumour clonogen repopulation during radiotherapy
2. The urinary tract
3. Idiopathic interstitial pneumonia following bone marrow transplantation: The relationship with total body irradiation
4. Changes in labeling indices of human tumors after irradiation
5. Short term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma
6. Comparison of conventional and split-course radiotherapy as primary treatment of the larynx
7. The influence of number of fractions and of overall treatment time on local control and late complication rate in squamous carcinoma of the larynx
8. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation
9. Clinical evidence for tumor clonogen regeneration: Interpretations of the data
10. No evidence for the influence of overall treatment time on TCD50 of head and neck tumors
11. Status of the experience of the EORTC Cooperative Group of radiotherapy with huperfractionated and accelerated radiotherapy regimes
12. Experience with CHART
13. Is there sufficient evidence for accelerated repopulation in tumors during radiotherapy?
14. Influence of treatment time on the response of the rat rhabdomyosarcoma R1H to fractionated irradiation
15. Changes in the rate of repopulation during multifraction irradiation of mouse skin
16. Accelerated repopulation of mouse tongue epithelium during fractionated radiotherapy or following single doses
17. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report
18. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry
19. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry
20. Potential for increasing the differential between tumors and normal tissues: Can proliferation rate be used?
21. Loss of local control with prolongation in radiotherapy
22. Accelerated fractionation vs. hyperfractionation: Rationales for several treatments per day
23. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851
24. Tumor cell kinetics local tumor control and accelerated radiotherapy A preliminary report
25. Prediction of cervical carcinoma response to radiotherapy
26. The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and radiosensitivity
27. What is known about tumour proliferation rates to choose between accelerated fractionation and hyperfractionation
28. Rapid repopulation in radiotherapy: A debate on mechanisms. The phantom of tumour treatment—Continually rapid proliferation unmasked
29. Rapid repopulation in radiotherapy: A debate on mechanisms. Accelerated repopulation in tumors and normal tissues
30. Tumor cell repopulation during fractionated radiotherapy: Correlation between flow cytometric and radiobiological data in three murine tumours
31. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample
32. Human tumor cell kinetics using a monoclonal antibody against iododcoxyuridine: Intratumoral sampling variations
33. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous carcinoma in the head and neck
34. Growth fractions in malignant non-Hodgkins lymphoma (NHL) as determined in situ with the monoclonal antibody Ki 67
35. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry
36. Application of intermediate filament proteins as tissue specific probes in the flow cytometric analysis of complex tumors
37. An improved method for computing the potential doubling time using monoclonal antibodies to bromodeoxyuridine
38. Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells
39. Cell kinetic analysis of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine